NG-001

N/A

Report date: 2024/03/08 14:48:40

Base Information

Drug NameNG-001
Drug Alias NameNG-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBase Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBase Therapeutics Ltd
Inactive CompaniesN/A
Active Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A